Oxygenator, Long Term Support Greater Than 6 Hours
Cardiovascular · 21 CFR 870.4100
Recent MDR events
178 adverse event reports on file
- MC3 ECMO OxygenatorJul 30, 2026MalfunctionPerfusion Systems2184009-2026-01200
- MC3 ECMO OXYGENATORJul 6, 2026MalfunctionMc3 Inc.3011468686-2026-00050
- MC3 ECMO OXYGENATORJul 3, 2026MalfunctionMc3 Inc.3011468686-2026-00048
- MC3 ECMO OXYGENATORJul 2, 2026MalfunctionMc3 Inc.3011468686-2026-00047
- MC3 ECMO OXYGENATORJun 29, 2026MalfunctionMc3 Inc.3011468686-2026-00046
- MC3 ECMO OXYGENATORJun 21, 2026InjuryMc3 Inc.3011468686-2026-00042
- MC3 ECMO OXYGENATORMay 22, 2026MalfunctionMc3 Inc.3011468686-2026-00039
- MC3 ECMO OXYGENATORMay 21, 2026MalfunctionMc3 Inc.3011468686-2026-00037
- MC3 ECMO OXYGENATORMay 20, 2026MalfunctionMc3 Inc.3011468686-2026-00036
- MC3 ECMO OXYGENATORMay 6, 2026MalfunctionMc3 Inc.3011468686-2026-00034
Event type breakdown
Recalls
2 recall events for this product code
- Mc3 IncOpen, ClassifiedMar 19, 2024
NautilusTM ECMO Oxygenator with Balance Biosurface-used in extracorporeal life support procedures to oxygenate blood, remove carbon dioxide and regulate blood t
May have increased water path restriction within the heat exchanger, leading to degraded heat exchange performance during use. The reduction of water flow and reduced heat exchange performance may be experienced immediately upon priming or may worsen over the duration of use. The potential harm as stated in the IFU includes hypothermia due to inadequate heat transfer
Z-1309-2024 · View FDA record ↗ - Mc3 IncOpen, ClassifiedMar 19, 2024
NautilusTM Smart ECMO Module with Balance Biosurface-used in extracorporeal life support procedures to oxygenate blood, remove carbon dioxide and regulate blood
May have increased water path restriction within the heat exchanger, leading to degraded heat exchange performance during use. The reduction of water flow and reduced heat exchange performance may be experienced immediately upon priming or may worsen over the duration of use. The potential harm as stated in the IFU includes hypothermia due to inadequate heat transfer
Z-1310-2024 · View FDA record ↗
Registered firms
11 firms currently registered for this product code